| Previous Close | 4.0000 |
| Open | 3.9600 |
| Bid | 3.8500 x 0 |
| Ask | 3.9600 x 0 |
| Day's Range | 3.8900 - 4.0000 |
| 52 Week Range | 3.5100 - 24.1206 |
| Volume | 3,846 |
| Avg. Volume | 60,947 |
| Market Cap | 50.501M |
| Beta (5Y Monthly) | 0.53 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.6560 |
| Earnings Date | May 14, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
FSD Pharma Reports Second Quarter 2020 Financial Results
\\- Provides Business Update -TORONTO / ACCESSWIRE / August 7, 2020 / FSD Pharma Inc.
- Business Wire
FSD Pharma Inc. Announces Closing of US$10 Million Registered Direct Offering to Institutional Investors
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) ("FSD Pharma" or the "Company") announces the closing of a previously announced agreement with investors for the purchase and sale of 2,762,430 Class B Subordinate Voting Shares of the Company ("Shares") and warrants to purchase 1,381,215 Shares (collectively, the "Securities") at a purchase price of US$3.62 per Share in a registered direct offering. Each Share was sold together with one-half of one warrant to purchase a Share. The warrants have an exercise price of US$4.26 per Share, are immediately exercisable and expire five years from the date of issuance.
- Newsfile
FSD Pharma Inc., Developing its PEA Compound to Treat COVID-19, CEO Clip Video
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) CEO and Chairman, Raza Bokhari speaks about the company's lead Compound, PEA, to treat COVID-19.If you cannot view the video above, please visit:https://www.b-tv.com/fsd-pharma-compound-to-treat-covid-19-ceo-clip-90sec/FSD Pharma will air on BIZTV throughout the month of August 2020, throughout the day and evenings.FSD Pharma Inc. (CSE: HUGE) (NASDAQ: HUGE) fsdpharma.comAbout CEO Clips:CEO Clips is the largest library of publicly traded company CEO ...
